Article
Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Oct 2016
Trost Sarah, Diekhof Esther K, Mohr Holger, Vieker Henning, Krämer Bernd, Wolf Claudia, Keil Maria, Dechent Peter, Binder Elisabeth B, Gruber Oliver
Abstract excerpt
Recent genome-wide association studies have identified MAD1L1 (mitotic arrest deficient-like 1) as a susceptibility gene for bipolar disorder and schizophrenia. The minor allele of the single-nucleotide polymorphism (SNP) rs11764590 in MAD1L1 was associated with bipolar disorder. Both diseases, bipolar disorder and schizophrenia, are linked to functional alterations in the reward system. We aimed at investigating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
